-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on United Therapeutics, Raises Price Target to $703

Benzinga·11/05/2026 15:21:26
Listen to the news
Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $700 to $703.